Congratulations to Dr. Yong Wan and his team for two recent high impact journal publications in the Journal of Clinical Investigation: "CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4," published March 5, 2024 "Pharmacological Suppression of the OTUD4-CD73 Proteolytic Axis Revives Antitumor Immunity against Immune-Cold Breast Cancers," published March 26, 2024.